XBIT — XBiotech Inc

Stock analysis, AI verdict, fundamentals & technical signals

Rating: NEUTRAL

Price: $1.88 Analyst target: $18.00 Upside: 857.45%

About XBiotech Inc

XBiotech Inc., a biopharmaceutical company, discovers, develops and markets True Human monoclonal antibodies for the treatment of various diseases. The company is headquartered in Austin, Texas.

See the full interactive analysis & chart →

Informational only — not investment advice.